Dr. Reddy's Laboratories announced the launch of Desmopressin Acetate Injection USP, 4 mcg/mL Single-dose Ampules, a therapeutic equivalent generic version of DDAVP (desmopressin acetate) Injection , 4 mcg/mL, approved by the U. S.

Food and Drug Administration (USFDA).

The DDAVP (desmopressin acetate) Injection USP brand and generic market had U. S. sales of approximately $20.9 million MAT for the most recent twelve months ending in March 2020 according to IQVIA Health.

Dr. Reddy's Desmopressin Acetate Injection USP, 4 mcg/mL is available in a carton of ten 1 mL singledose ampules.

Powered by Capital Market - Live News

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)